MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
3. Government ... Funders, Regulators, Policy Makers, Conveners
*Government: International
Europe
*Europe: Regions
*Western Europe
Ireland
*Industry: Ireland
Ipsen SA (OTC: IPSEY)
Finance & Acquisitions: Ipsen
Parents
Ipsen SA (OTC: IPSEY)
Children
2022: Ipsen S.A. 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2022: Ipsen to Acquire Epizyme - Growth in Oncology
2023: Ipsen to Acquire Albireo for Rare Disease Portfolio
2025: Ipsen S.A. 2024 Q4 - Results - Earnings Call Presentation
2026: Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus antibody, expanding rare disease portfolio
Albireo Pharma, Inc. (Nasdaq: ALBO)
Clementia Pharmaceuticals Inc. (CMTA)
Epizyme (NASDAQ: EPZM)
Memo Therapeutics AG
Revenue: 287 billion EUR (2021)
Jumps
*Key People: Ipsen
Organization & Developments: Ipsen